Menu
The Think Tank on Advancing Precision Medicine in Rare Cancers was a highly interactive, one-day meeting held in Boston in November 2023. Uniting clinicians, researchers, industry, patient advocates and patients, the unique format of this meeting promoted collaboration, information sharing, and idea generation. The diverse perspectives of speakers and attendees allowed for a comprehensive discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers.
View the 2023 Think Tank Agenda.
View photos from the 2023 Think Tank.
The Think Tank on Advancing Precision Medicine in Rare Cancers leveraged the successful “think tank” model that TargetCancer Foundation has established through over a decade of meetings on other topics, such as gastroesophageal cancers. This meeting also builds on the progress being made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers.
We are grateful to our industry partners for their support of these meetings, and their dedication to developing treatments for patients with rare cancers.
You can also view last year’s 2022 Think Tank agenda, photos, and a mock Molecular Tumor Board meeting featuring members of the TRACK Virtual Molecular Tumor Board.